http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 AMSTERDAM, November 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in the field of human gene therapy, today provides its non-audited business update in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4005 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4005 Wed, 18 Nov 2009 06:00:00 +0000 KVISTGARD, Denmark, November 11 /PRNewswire/ -- Today Bavarian Nordic published the company's third quarterly report 2009. The full report including the financial statements is available on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3966 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3966 Wed, 11 Nov 2009 13:41:00 +0000 PEMBROKE, Bermuda, November 5 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today reported net income of $200.6 million, or $3.83 per diluted share, for the third quarter... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3939 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3939 Thu, 05 Nov 2009 23:19:00 +0000 TOKYO, October 30 /PRNewswire/ -- HOYA Corporation today announced financial results for the second quarter ended September 30, 2009. Net sales were 106.8 billion yen for the quarter, a 16.8%... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3905 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3905 Fri, 30 Oct 2009 16:39:00 +0000 DUBLIN, October 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3901 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3901 Fri, 30 Oct 2009 13:08:00 +0000 AURORA, Ontario, October 30 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: HBP / OTCQX: HXBPF) today announced financial results for the year ended July 31, 2009. During the 2009 fiscal year,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3896 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3896 Fri, 30 Oct 2009 01:48:00 +0000 MCKINNEY, Texas, October 28 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended September 30, 2009, net income was US$1.22 per share compared with US$.72 per... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3887 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3887 Wed, 28 Oct 2009 20:00:00 +0000 CHARENTON-LE-PONT, France, October 22 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3846 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3846 Thu, 22 Oct 2009 06:25:00 +0000 ANTONY, France, October 15 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3815 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3815 Thu, 15 Oct 2009 19:59:00 +0000 LACHEN, Switzerland, October 2 /PRNewswire/ -- Through June 2009, Octapharma AG realized a record turnover of 536 M euro, compared to 422 M euro as of year-to-date June 2008, an increase of 27%. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3750 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3750 Fri, 02 Oct 2009 20:01:00 +0000 VEENENDAAL, the Netherlands, September 3 /PRNewswire/ -- Nucletron, a global leader in radiation oncology, today announced strong financial results over the first half year of 2009. Despite... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3573 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3573 Thu, 03 Sep 2009 08:00:00 +0000 KVISTGAARD, Denmark, August 28 /PRNewswire/ -- Today Bavarian Nordic published the company's half-year interim report 2009. The full financial statements are available on the company's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3528 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3528 Fri, 28 Aug 2009 08:45:00 +0000 LEUVEN, Belgium, August 27 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3525 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3525 Thu, 27 Aug 2009 17:54:00 +0000 PARIS, August 27 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3520 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3520 Thu, 27 Aug 2009 07:24:00 +0000 PARIS, August 26 /PRNewswire/ -- The Board of Directors, meeting on 25 August 2009 under the chairmanship of Albert Saporta approved the 2009 half year financial statements: http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3518 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3518 Wed, 26 Aug 2009 18:00:00 +0000 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3465 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3465 Thu, 13 Aug 2009 06:00:00 +0000 LONDON, August 5 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to June 30, 2009. Q2 2009 Financial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3443 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3443 Wed, 05 Aug 2009 13:26:00 +0000 TOKYO, Japan, August 3 /PRNewswire/ -- HOYA Corporation today announced financial results for the first quarter ended June 30, 2009. Net sales were 94.9 billion yen for the quarter, a 27.0% decrease... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3431 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3431 Mon, 03 Aug 2009 11:07:00 +0000 LONDON, July 23 /PRNewswire/ -- Misys, the banking and healthcare software group, reported continued growth despite the turmoil in financial markets. The group's full year results have been... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3400 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3400 Thu, 23 Jul 2009 07:52:00 +0000 LONDON, July 22 /PRNewswire/ -- GSK announced its sales and turnover fell by less than expected in Q2. The Pharma giant also said there had been good growth in the consumer, vaccine, european and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3397 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3397 Wed, 22 Jul 2009 13:06:00 +0000 CHARENTON-LE-PONT, France, July 17 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3386 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3386 Fri, 17 Jul 2009 06:37:00 +0000 ANTONY, France, July 15 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3375 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3375 Wed, 15 Jul 2009 17:57:00 +0000 HORSHOLM, Denmark, July 14 /PRNewswire/ -- The Board of Directors of Santaris Pharma has approved the Interim Report for the period 1 January to 30 June 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3364 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3364 Tue, 14 Jul 2009 14:14:00 +0000 NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3055 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3055 Fri, 15 May 2009 21:20:00 +0000 PHILADELPHIA and DUBLIN, April 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to March 31, 2009. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2977 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2977 Thu, 30 Apr 2009 12:00:00 +0000 DUSSELDORF, Germany, April 29 /PRNewswire/ -- The Annual General Meeting of Gerresheimer AG today passed an unchanged dividend of EUR0.40 per share following the record year in 2008. The Company... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2970 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2970 Wed, 29 Apr 2009 14:03:00 +0000 KVISTGAARD, Denmark, April 28 /PRNewswire/ -- Yesterday Bavarian Nordic Announced its Interim Results for the First Quarter of 2009 - Positive Developments in the Biodefence and Cancer Business... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2959 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2959 Tue, 28 Apr 2009 12:19:00 +0000 VEENENDAAL, The Netherlands, April 24 /PRNewswire/ -- Nucletron, a global leader in radiation oncology, today announced strong financial results in 2008 with net sales of EUR112.4 million (US... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2942 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2942 Fri, 24 Apr 2009 08:35:00 +0000 CHARENTON-LE-PONT, France, April 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR840.4 million for the three months ended... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2934 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2934 Thu, 23 Apr 2009 06:25:00 +0000 MCKINNEY, Texas, April 22 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2009, net income was US$.91 per share (after a charge of US$.49 per... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2931 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2931 Wed, 22 Apr 2009 21:01:00 +0000 BRACKNELL, England, April 21 /PRNewswire/ -- Boehringer Ingelheim maintained its growth path in 2008 too, thereby meeting the goals it had set itself. As the company announced at its Annual... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2920 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2920 Tue, 21 Apr 2009 13:16:00 +0000 DUBLIN, Ireland, April 20 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce first quarter 2009 earnings on Thursday April 30, 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2913 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2913 Mon, 20 Apr 2009 17:41:00 +0000 ANTONY, France, April 15 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2884 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2884 Wed, 15 Apr 2009 18:01:00 +0000 BOLZANO, Italy, April 14 /PRNewswire/ -- Health Robotics today announced audited results for FY2008 ending December 31, 2008, delivering record levels of firm purchase orders, revenue, earnings and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2880 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2880 Tue, 14 Apr 2009 14:00:00 +0000 DUSSELDORF, Germany, April 2 /PRNewswire/ -- In the first quarter of 2009 (December 2008 to February 2009) Gerresheimer AG maintained its total sales figure of EUR237.3m (Q1 2008: EUR239.1m) almost... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2826 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2826 Thu, 02 Apr 2009 07:41:00 +0000 NAPA, California, March 31 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2818 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2818 Tue, 31 Mar 2009 21:15:00 +0000 KVISTGAARD, Denmark, March 27 /PRNewswire/ -- Today Bavarian Nordic published the company's Annual Report 2008. The report is available on the company's website: http://www.bavarian-nordid.com. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2792 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2792 Fri, 27 Mar 2009 08:00:00 +0000 DUBLIN, March 25 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its Annual Report and Accounts in respect of the year ended... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2780 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2780 Wed, 25 Mar 2009 14:09:00 +0000 ANTONY, France, March 24 /PRNewswire/ -- The Board of Directors, meeting on 23 March 2009 under the chairmanship of Albert SAPORTA, approved the 2008 consolidated financial statements: http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2770 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2770 Tue, 24 Mar 2009 18:45:00 +0000 LONDON, March 17 /PRNewswire/ -- Hikma Pharmaceuticals today announced strong revenue growth and stable net profits despite a loss at the company's US Generics business. The weakness in the US was... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2715 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2715 Tue, 17 Mar 2009 07:41:00 +0000 LEUVEN, Belgium, March 12 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments that will make a real... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2706 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2706 Thu, 12 Mar 2009 17:04:00 +0000 CHARENTON-LE-PONT, France, March 5 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2666 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2666 Thu, 05 Mar 2009 07:24:00 +0000 AMSTERDAM, the Netherlands, February 24 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the year of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2600 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2600 Tue, 24 Feb 2009 06:00:00 +0000 PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 19 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the year to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2577 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2577 Thu, 19 Feb 2009 12:42:00 +0000 AMSTERDAM, The Netherlands, February 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it will release... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2575 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2575 Wed, 18 Feb 2009 20:00:00 +0000 LONGJUMEAU, France, February 18 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2574 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2574 Wed, 18 Feb 2009 17:30:00 +0000 PHILADELPHIA and DUBLIN, Ireland, February 9 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce full year 2008 earnings on Thursday 19... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2530 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2530 Mon, 09 Feb 2009 12:00:00 +0000 TOKYO, February 5 /PRNewswire/ -- HOYA Corporation today announced financial results for the third quarter ended December 31, 2008. Net sales were 112.7 billion yen for the quarter, representing a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2523 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2523 Thu, 05 Feb 2009 17:00:00 +0000 LONDON, February 5 /PRNewswire/ -- In a video interview Andrew Witty, GlaxoSmithKline CEO, described the pharmaceutical group's results as "robust" in a year that was "always going to be... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2522 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2522 Thu, 05 Feb 2009 13:24:00 +0000 MUMBAI, India, January 30 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) reported continuing growth for the third quarter ending... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2500 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2500 Fri, 30 Jan 2009 16:58:00 +0000 CHARENTON-LE-PONT, France, January 29 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR3,074.5 million for the year... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2493 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2493 Thu, 29 Jan 2009 07:03:00 +0000 ANTONY, France, January 15 /PRNewswire/ -- (1) Portugal, Spain, France, Italy, Greece; (2) Switzerland included http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2423 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2423 Thu, 15 Jan 2009 18:08:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, December 5 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), an innovative molecular diagnostic company leveraging microRNAs as biomarkers, reported... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2259 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2259 Fri, 05 Dec 2008 12:30:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, December 2 /PRNewswire/ -- In the news release, "Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results" issued on 26... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2234 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2234 Tue, 02 Dec 2008 13:30:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, November 26 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release third quarter financial results on December 5, 2008, before... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2206 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2206 Wed, 26 Nov 2008 21:30:00 +0000 HAIFA, Israel, November 20 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2168 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2168 Thu, 20 Nov 2008 07:32:00 +0000 NAPA, California, November 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2135 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2135 Fri, 14 Nov 2008 21:30:00 +0000 GIBRALTAR, November 13 /PRNewswire/ -- Over a year into the smoking ban in the UK and more than 53 land based bingo halls have closed, bringing the number of clubs still open to about 550. Yes, the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2125 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2125 Thu, 13 Nov 2008 12:36:00 +0000 SAN DIEGO, November 11 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced financial results for the third quarter and nine months ended September 30, 2008, and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2100 Tue, 11 Nov 2008 12:30:00 +0000 BIRMINGHAM, England, November 11 /PRNewswire/ -- The Binding Site Limited ("The Binding Site" or the "Company"), a privately-owned specialist UK diagnostics company, today announces a trading update... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2096 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2096 Tue, 11 Nov 2008 08:00:00 +0000 TOKYO, November 10 /PRNewswire/ -- HOYA Corporation today announced financial results for the second quarter ended September 30, 2008. Net sales were 128.3 billion yen for the quarter, representing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2084 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2084 Mon, 10 Nov 2008 12:12:00 +0000 KVISTGARD, Denmark, November 4 /PRNewswire/ -- In the first nine months of 2008 Bavarian Nordic generated revenue of DKK 45 million and recorded a loss before tax of DKK 195 million. The expectations... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2044 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2044 Tue, 04 Nov 2008 07:44:00 +0000 COPENHAGEN, Denmark, October 29 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the nine month period ended September 30, 2008. During this period, Genmab reported the following... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2020 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2020 Wed, 29 Oct 2008 21:54:00 +0000 COPENHAGEN, Denmark, October 29 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the nine month period ended September 30, 2008. During this period, Genmab reported the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2017 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2017 Wed, 29 Oct 2008 18:40:00 +0000 PHILADELPHIA, Pennysylvania and DUBLIN, Ireland, October 29 /PRNewswire/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2011 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2011 Wed, 29 Oct 2008 12:42:00 +0000 ANTONY, France, October 27 /PRNewswire/ -- Stallergenes has just obtained authorization (IND(1)) from the FDA for immediately launching a phase III clinical trial in the United States with Oralair(R)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1992 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1992 Mon, 27 Oct 2008 18:00:00 +0000 MUMBAI, India, October 25 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) reported strong growth for the second quarter ending Sep... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1983 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1983 Sat, 25 Oct 2008 11:42:00 +0000 CHARENTON-LE-PONT, France, October 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1968 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1968 Thu, 23 Oct 2008 06:28:00 +0000 ANTONY, France, October 15 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1924 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1924 Wed, 15 Oct 2008 18:24:00 +0000 D http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1915 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1915 Wed, 15 Oct 2008 07:31:00 +0000 LEUVEN, Belgium, August 28 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, is today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1590 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1590 Thu, 28 Aug 2008 16:45:00 +0000 CHARENTON-LE-PONT, France, August 28 /PRNewswire/ -- The Board of Directors of Essilor International, the world leader in ophthalmic optics, has approved the financial statements for the six months... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1584 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1584 Thu, 28 Aug 2008 06:36:00 +0000 COPENHAGEN, August 27 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the six month period ended June 30, 2008. During this period, Genmab reported the following results: ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1581 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1581 Wed, 27 Aug 2008 17:37:00 +0000 ANTONY, France, August 27 /PRNewswire/ -- The Board of Directors, meeting today under the chairmanship of Albert Saporta, approved STALLERGENES' half year consolidated financial statements: http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1580 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1580 Wed, 27 Aug 2008 17:21:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, August 19 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based diagnostic and therapeutic products, reported today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1542 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1542 Tue, 19 Aug 2008 09:30:00 +0000 NAPA, California, August 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1535 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1535 Thu, 14 Aug 2008 21:15:00 +0000 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2008. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1511 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1511 Wed, 13 Aug 2008 11:38:00 +0000 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2008. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1528 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1528 Wed, 13 Aug 2008 11:38:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, August 12 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on August 19, 2008, before the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1508 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1508 Tue, 12 Aug 2008 21:30:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, August 12 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on August 19, 2008, before the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1525 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1525 Tue, 12 Aug 2008 21:30:00 +0000 SAN DIEGO, August 12 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today financial results for the second quarter and six months ended June 30, 2008, and highlighted... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1506 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1506 Tue, 12 Aug 2008 12:30:00 +0000 SAN DIEGO, August 12 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today financial results for the second quarter and six months ended June 30, 2008, and highlighted... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1523 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1523 Tue, 12 Aug 2008 12:30:00 +0000 AMSTERDAM, The Netherlands, August 5 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release its financial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1483 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1483 Tue, 05 Aug 2008 06:00:00 +0000 LONDON, July 24 /PRNewswire/ -- Key Highlights Misys plc (FTSE: MSY.L) delivers results ahead of expectations and is now raising targets for the next phase of the turnaround. Misys generated... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1442 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1442 Thu, 24 Jul 2008 07:00:00 +0000 LONDON, July 23 /PRNewswire/ -- In a video interview, new CEO Andrew Witty comments on GSK's second quarter results while also updating the market on his strategic vision for the business. The... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1439 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1439 Wed, 23 Jul 2008 15:16:00 +0000 CHARENTON-LE-PONT, France, July 17 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR1,520.3 million for the six months... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1407 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1407 Thu, 17 Jul 2008 06:10:00 +0000 DÜSSELDORF, Germany, July 15 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1392 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1392 Tue, 15 Jul 2008 07:17:00 +0000 ANTONY, France, July 10 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1377 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1377 Thu, 10 Jul 2008 18:17:00 +0000 BASINGSTOKE, England and PHILADELPHIA, July 4 /PRNewswire/ -- Shire Limited (LSE:SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2008 earnings on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1350 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1350 Fri, 04 Jul 2008 12:00:00 +0000 BIRMINGHAM, England, June 30 /PRNewswire/ -- The Binding Site Limited ("The Binding Site" or the "Company"), a privately owned specialist UK diagnostics company, today announces its results for the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1315 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1315 Mon, 30 Jun 2008 08:35:00 +0000 REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, May 21 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1051 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1051 Wed, 21 May 2008 13:30:00 +0000 NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1010 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1010 Thu, 15 May 2008 22:00:00 +0000 PRINCETON, New Jersey, May 15 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1009 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1009 Thu, 15 May 2008 21:15:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, May 14 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on May 21, 2008, before the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/992 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/992 Wed, 14 May 2008 13:30:00 +0000 ATHENS, May 13 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/985 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/985 Tue, 13 May 2008 17:42:00 +0000 ST. DAVID'S, Bermuda, May 9 /PRNewswire/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2008. Revenue in the quarter ended March 31,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/957 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/957 Fri, 09 May 2008 12:00:00 +0000 TOKYO, Japan, April 28 /PRNewswire/ -- HOYA Corporation today announced fourth quarter net sales of 135.8 billion yen for the period ended March 31, 2008, a 36.5% increase over the same quarter of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/888 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/888 Mon, 28 Apr 2008 17:30:00 +0000 BASINGSTOKE, England and PHILADELPHIA, April 25 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to March... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/867 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/867 Fri, 25 Apr 2008 12:00:00 +0000 CHARENTON-LE-PONT, France, April 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR762.2 million for the three months ended... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/838 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/838 Wed, 23 Apr 2008 05:58:00 +0000 MCKINNEY, Texas, April 16 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2008, net income was US$1.29 per share compared with US$1.37 per share... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/809 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/809 Wed, 16 Apr 2008 21:00:00 +0000 PARIS, April 15 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/799 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/799 Tue, 15 Apr 2008 19:48:00 +0000 DÜSSELDORF, Germany, April 14 /PRNewswire/ -- Gerresheimer AG has started the financial year 2008 with an outstanding first quarter. Sales grew by 18.2% compared with the prior year period to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/780 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/780 Mon, 14 Apr 2008 06:15:00 +0000 WASHINGTON DC, April 2 /PRNewswire/ -- Bavarian Nordic, the Danish-based biopharmaceutical company, recently published its 2007 Annual Report. Below is an extract of the most significant matters in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/722 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/722 Wed, 02 Apr 2008 13:00:00 +0000 PRINCETON, New Jersey, April 1 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced record growth in revenues for 2007.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/655 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/655 Tue, 01 Apr 2008 12:00:00 +0000 COPENHAGEN, March 31 /PRNewswire/ -- In order to read Genmab's 2007 Annual Report please click on the following url: ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/649 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/649 Mon, 31 Mar 2008 22:52:00 +0000 COPENHAGEN, Denmark, March 31 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the financial year ended December 31, 2007. Revenues of DKK 530 million (approximately USD 104... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/648 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/648 Mon, 31 Mar 2008 22:18:00 +0000 KVISTGARD, Denmark, March 31 /PRNewswire/ -- Today Bavarian Nordic published the company's Annual Report 2007. The report is available on the company's website. Below is an extract of the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/640 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/640 Mon, 31 Mar 2008 11:47:00 +0000 PLANEGG-MARTINSRIED, Germany, March 27 /PRNewswire/ -- 4SC AG (Frankfurt, Prime Standard: VSC) reports today on the financial result of the financial year 2007. Revenues during the reporting... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/623 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/623 Thu, 27 Mar 2008 08:00:00 +0000 BASINGSTOKE, England, March 25 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces its preliminary results prepared under International... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/610 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/610 Tue, 25 Mar 2008 15:12:00 +0000 LEUVEN, Belgium, March 13 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular diseases, today announces a business update and its financial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/702 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/702 Thu, 13 Mar 2008 16:45:00 +0000 PARIS, March 12 /PRNewswire/ -- - Further Profit Growth http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/693 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/693 Wed, 12 Mar 2008 18:16:00 +0000 CHARENTON-LE-PONT, France, March 6 /PRNewswire/ -- - Another Year of Solid Performance http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/663 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/663 Thu, 06 Mar 2008 07:39:00 +0000 DÜSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of EUR957.7m, up by 48.1%;... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/577 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/577 Mon, 04 Feb 2008 09:04:00 +0000 DUSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of EUR957.7m, up by 48.1%;... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/576 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/576 Mon, 04 Feb 2008 09:01:00 +0000 DÜSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of EUR957.7m, up by 48.1%;... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/574 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/574 Mon, 04 Feb 2008 08:57:00 +0000 COPENHAGEN, Denmark, January 31 /PRNewswire/ -- Genmab A/S (OMX: GEN) announces its financial calendar for 2008 as follows: http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/559 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/559 Thu, 31 Jan 2008 08:22:00 +0000